How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Teva: Warren Buffett Messed Things Up For Short-Sellers - Bloomberg
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg - Benzinga
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion
Teva Gets Generic Price-Fixing Securities Suits Consolidated
Allergan becomes largest shareholder in Teva - Globes
The Difficulties of Cloning a CEO - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva's $225 Million Opioid Deal With Texas Is Its Biggest (2)
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva's job-cut tally could touch 10K: report | Fierce Pharma
Teva Pharmaceuticals Sued by U.S. Over Medicare Kickback Claims - BNN Bloomberg
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Drug giants line up for Irish legal battle over patents - Independent.ie
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva CEO Says Drugmaker Will Fight US Price-Fixing Charges (2)
Teva bid for Mylan could come today - Bloomberg - Jewish Business News
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
